Please wait
Healthcare · Healthcare Plans · Price, fundamentals, signals, and forward-looking context in one research view.
Healthcare
$31.7B
N/A
N/A
Current price
$63.87
-1.4% todayUpdated 2 min ago
Open
$65.41
Previous close
$64.75
Day range
$63.42 – $65.74
Volume
N/A
Limited data
Awaiting filing
No current yield
65/100 measured
Easy to trade
Recent price movement, key market context and the latest company information.
The latest saved price history for CNC, with its range and direction at a glance.
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Investors usually follow CNC for its valuation signal, sector position, and upcoming company events. The goal here is not just to show numbers, but to explain what they mean in plain English.
Whisone is bullish because fundamentals are solid at 71/100 while there is no strong bear warning from the current data. Whisone has moderate conviction here. The final read is being balanced by the weighted scores for fundamentals, technicals, insider flow, sentiment, event flow, and liquidity.
Whisone v2 splits the read into weighted parts so the score is not just one hidden number.
Fundamentals
Growth, margins, cash flow, and valuation.
Latest net profit
$1.09B
TTM (2026-06-30)
ROE
-20.4%
Return on equity
ROA
2.5%
Return on assets
Debt / equity
0.71
Lower is usually safer.
P/B ratio
1.41
Useful for book value support.
85/100
Direction
Range-bound
Main supports
Business quality and balance-sheet strength are supporting the outlook.
Recent price and fundamentals refreshes improve signal reliability.
What can go wrong
Volatility is elevated, so the path can stay rough even if the thesis is right.
Fair value
$68.21
Analyst view
Buy
Analyst target
$71.67
Forecast refresh
Updated 11h ago
Quality score
70
Growth score
50
These are the external analyst numbers and business outlook figures already synced into the company record.
No external analyst outlook is available for this company yet.
A plain-English reading of momentum, trend, volatility, range position, and trading participation.
RSI
N/A
Momentum data is not available yet.
Recent trend
Rising
+2.7% across the latest saved price window.
Volatility
Moderate
Beta is 1.10. Price sensitivity is broadly around the market range.
52-week position
87% of range
Price is trading close to its 52-week high.
Volume confirmation
N/A
Comparable volume data is not available.
AbbVie Inc.
Price: $256.28
P/E: 72.994286
Yield: 2.7%
ABT
Abbott Laboratories
Price: $110.18
P/E: 36.39806
Yield: 2.3%
ALGN
Align Technology, Inc.
Price: $158.10
P/E: 27.310226
Yield: 0.0%
Industry
Healthcare Plans
Employees
61100
Exchange
NYQ
Ticker
CNC
